z-logo
open-access-imgOpen Access
Antifungal hydrogels
Author(s) -
Andreas Zumbuehl,
Lino Ferreira,
Duncan M. Kuhn,
Anna Astashkina,
Lisa Long,
Yoon Yeo,
Tiffany Iaconis,
Mahmoud A. Ghannoum,
Gerald R. Fink,
Róbert Langer,
Daniel S. Kohane
Publication year - 2007
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0705250104
Subject(s) - candida albicans , amphotericin b , hemolysis , antifungal , biofilm , microbiology and biotechnology , self healing hydrogels , corpus albicans , in vivo , biology , chemistry , bacteria , immunology , genetics , organic chemistry
Fungi are increasingly identified as major pathogens in bloodstream infections, often involving indwelling devices. Materials with antifungal properties may provide an important deterrent to these infections. Here we describe amphogel, a dextran-based hydrogel into which amphotericin B is adsorbed. Amphogel kills fungi within 2 h of contact and can be reused for at least 53 days without losing its effectiveness against Candida albicans. The antifungal material is biocompatible in vivo and does not cause hemolysis in human blood. Amphogel inoculated with C. albicans and implanted in mice prevents fungal infection. Amphogel also mitigates fungal biofilm formation. An antifungal matrix with these properties could be used to coat a variety of medical devices such as catheters as well as industrial surfaces.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom